Kura Oncology Inc
Statements
Cash Flow
Kura Oncology Inc (KURA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -63 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.5 | -6.7 | -8.6 | -6.1 | -6.2 | -7.5 | -13 | -13 | -13 | -10 | -14 | -14 | -12 | -14 | -20 | -15 | -17 | -18 | -29 | -28 | -25 | -23 | -32 | -30 | -21 | -27 | -36 | -26 | -29 | -34 | -49 | -43 | -43 | 269 | -72 | -29 | -81 | 117 | -86 | -63 | -112 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.9 | -0.5 | -0.3 | -0.1 | -1.1 | -0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 1.7 | 0.4 | 0.4 | 2.6 | |
| 0.6 | 0.6 | 0.9 | 1.0 | 1.2 | 1.4 | 2.2 | 2.2 | 2.5 | 1.7 | 2.3 | 2.2 | 2.5 | 2.4 | 3.2 | 2.6 | 3.4 | 3.7 | 5.1 | 6.0 | 6.1 | 6.4 | 6.7 | 6.5 | 6.4 | 6.8 | 6.8 | 7.0 | 7.1 | 7.2 | 8.5 | 8.4 | 8.3 | 8.6 | 7.8 | 6.9 | 11 | 11 | 8.4 | 8.2 | 39 | |
| 0.6 | 2.3 | 0.9 | 1.0 | 1.2 | 4.4 | 2.2 | 2.2 | 2.5 | 2.2 | 2.3 | 2.2 | 2.5 | 2.4 | 3.2 | 2.6 | 3.4 | 3.7 | 5.1 | 7.7 | 6.1 | 6.4 | 6.7 | 6.5 | 6.4 | 6.9 | 6.8 | 5.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.8 | 0.0 | -2.0 | 0.7 | 2.0 | 2.0 | -0.2 | 0.3 | 0.0 | 4.3 | -2.0 | -1.4 | 1.9 | -0.5 | -1.3 | 1.4 | 0.7 | -0.1 | -2.4 | -1.0 | 1.2 | 1.6 | -2.4 | -2.7 | 1.2 | 1.7 | -7.3 | 2.2 | 1.1 | 3.7 | -4.9 | 3.1 | 0.1 | 282 | -20 | 36 | -44 | 188 | -20 | -42 | 81 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.7 | 0.7 | 0.3 | 0.0 | 0.3 | 0.7 | 0.1 | 0.0 | 0.2 | 0.4 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.4 | 0.3 | 1.5 | 2.6 | 2.3 | 0.1 | 0.7 | 5.7 | |
| 0.1 | 9.7 | 9.5 | 7.4 | -36 | -4.1 | -30 | 3.9 | -58 | 4.6 | 16 | 8.9 | -56 | -15 | 27 | -22 | -46 | -60 | -186 | -37 | 23 | 74 | -25 | 33 | 72 | -47 | 11 | -46 | 8.6 | 42 | -95 | 43 | 46 | -95 | -101 | 59 | 94 | -65 | -24 | 92 | 97 | |
| 0.0 | 54 | 0.0 | 0.2 | 54 | 54 | 58 | 0.1 | 75 | -0.3 | 0.1 | 108 | -0.2 | 0.0 | 0.2 | 135 | -0.2 | 324 | 0.8 | – | – | – | 0.3 | 2.7 | 0.9 | 25 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 7.5 | -0.3 | -0.3 | -0.3 | -0.6 | -0.3 | -0.3 | -0.8 | 0.4 | – | – | – | – | -0.3 | -0.3 | -0.3 | -0.3 | -0.8 | -6.5 | – | – | – | – | 10 | 9.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 7.5 | 7.5 | 0.0 | 0.2 | 54 | -0.3 | 58 | -0.1 | 74 | 1.1 | 0.1 | 110 | 0.6 | 0.6 | 0.2 | 137 | 4.7 | 327 | 0.1 | -6.6 | 2.3 | 0.8 | 0.3 | 2.7 | 0.9 | 35 | 94 | 94 | 0.1 | 0.7 | 148 | 3.0 | 2.2 | 0.8 | 0.1 | 0.5 | 0.0 | 1.1 | 0.1 | 1.5 | 2.7 | |
| -5.3 | 2.9 | 0.9 | 1.5 | 11 | -12 | 15 | -8.9 | 2.9 | -4.4 | 1.7 | 104 | -67 | -29 | 7.9 | 101 | -58 | 249 | -215 | -72 | 0.2 | 51 | -57 | 5.4 | 51 | -39 | -25 | 22 | -20 | 8.6 | 4.2 | 3.7 | 4.3 | 175 | -173 | 31 | 13 | 54 | -110 | 31 | -12 | |
| -5.5 | -6.7 | -8.6 | -6.1 | -6.2 | -7.5 | -13 | -13 | -13 | -10 | -14 | -14 | -12 | -14 | -20 | -15 | -18 | -19 | -29 | -28 | -25 | -23 | -32 | -31 | -21 | -27 | -36 | -26 | -29 | -34 | -49 | -43 | -43 | 269 | -72 | -30 | -83 | 115 | -86 | -63 | -117 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.